(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
April 2021

Former Merck Executive Michael T. Nally to Lead Generate Biomedicines as Chief Executive Officer

Generate Biomedicines has hired Michael T. Nally as Chief Executive Officer. He joins from an 18-year career with Merck, where he was most recently Executive Vice President and Chief Marketing Officer for the Human Health division. During his tenure with Merck, he previously served in such leadership roles as President of Global Vaccines, Managing Director of UK & Ireland, and Managing Director of Sweden. Through his experiences with Merck, Michael gained expertise across global marketing strategy, commercialization, and growth strategies, as well as experience in commercial operations, business development and investor relations.

Generate Biomedicines is an early-stage life sciences company pioneering a machine learning– powered biomedicines platform with the potential to generate new drugs on demand across a wide range of biologic modalities—from short peptides to complex antibodies, enzymes, cytokines, and yet to be described protein compositions. Generate Biomedicines was founded by Flagship Pioneering, and is headquartered in Cambridge, MA